Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for penicillin root_references_citation in Reference Text / Citation (approximate match)

Showing 181 - 190 of 243 results

First page
Previous page
Next page
Next page

POVIDONE K12

333AG72FWJ

Status:

Possibly Marketed Outside US

Source:

ANDA040103

(1996)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbc84ea2-5f87-403d-ab4d-f1abd0e22dad

First approved in 1996

Source:

ANDA040103

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbc84ea2-5f87-403d-ab4d-f1abd0e22dad

Class:

POLYMER

POVIDONE K30

U725QWY32X

Status:

Possibly Marketed Outside US

Source:

part349

Source URL:

https://www.drugbank.ca/drugs/DB14478

First approved in 1971

Source:

NADA055030

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61be8261-ac3d-418a-a414-62c64d9eacc0

Class:

POLYMER

Rildinadstrocel

3ME9TTI5QB

Status:

Investigational

Source:

NCT04661644: Phase 1/Phase 2 Interventional Completed Critical Limb Ischemia

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04661644

Class:

STRUCTURALLY DIVERSE

ROMYELOCEL-L

BEX65U1K6I

Status:

Investigational

Source:

NCT02282215: Phase 2 Interventional Completed Acute Myeloid Leukemia

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02282215

Class:

STRUCTURALLY DIVERSE

SARS-COV2

B6L4N5Z4GH

Status:

Investigational

Source:

NCT04387760: Phase 2 Interventional Completed SARS-CoV 2

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04387760

Class:

STRUCTURALLY DIVERSE

anti-human T-lymphocyte immunoglobulin from rabbits

5BFK6XZP8E

Status:

Other

Class:

STRUCTURALLY DIVERSE

Mumps Virus Genotype A strain JL2 isolate

2W4B624Z8W

Status:

Other

Class:

STRUCTURALLY DIVERSE

IW-001

6H38BT5EEZ

Status:

Other

Class:

STRUCTURALLY DIVERSE

R-AD26-S (RECOMBINANT ADENOVIRUS TYPE 26 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)

C3JH443FGL

Status:

Other

Class:

STRUCTURALLY DIVERSE

R-AD5-S (RECOMBINANT ADENOVIRUS TYPE 5 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)

TJ5C56A5DW

Status:

Other

Class:

STRUCTURALLY DIVERSE

Structure of POVIDONE K12

Polymer

Structure of POVIDONE K30

Polymer

Structurally Diverse

Rildinadstrocel

Structurally Diverse

ROMYELOCEL-L

Structurally Diverse

SARS-COV2

Structurally Diverse

anti-human T-lymphocyte immunoglobulin from rabbits

Structurally Diverse

Mumps Virus Genotype A strain JL2 isolate

6H38BT5EEZ
Not a public record

Structurally Diverse

IW-001

Structurally Diverse

R-AD26-S (RECOMBINANT ADENOVIRUS TYPE 26 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)

Structurally Diverse

R-AD5-S (RECOMBINANT ADENOVIRUS TYPE 5 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)

Showing 181 - 190 of 243 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1